Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Rubella Diagnostic Testing Industry By 2029?

In recent times, there has been significant growth in the market size of rubella diagnostic testing. The market is predicted to expand from $1.3 billion in 2024 to $1.39 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this historic period growth includes an increase in vaccination campaigns, a surge in the occurrence of outbreaks that can be prevented by immunization, government strategies to fight against the rubella virus, and the broadening of diagnostic testing into non-conventional environments.

In the coming years, robust expansion is predicted for the rubella diagnostic testing market. It is projected to escalate to $1.78 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.5%. The anticipated rise during the forecast period could be due to factors such as heightened healthcare expenditures, increased emphasis on preventive healthcare, escalating consciousness of diseases preventable by vaccination, the proliferation of public health campaigns, and the surge of telemedicine and remote diagnosis. Key trends in the forecast timeframe consist of progress in diagnostic technologies, the incorporation of technology in healthcare systems, the evolution of point-of-care testing solutions, the creation of innovative diagnostic methods, and progress in molecular diagnostics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19177&type=smp

Which Growth Drivers Are Shaping The Rubella Diagnostic Testing Market Outlook?

The surge in viral infection rates is forecasted to foster the expansion of the rubella diagnostic testing market. Viral infections are diseases spurred by viruses, minute infectious entities that can only proliferate within the living cells of a being. The surge is attributed to augmented global travel, which is a conduit for inter-border virus transmission, and climate change, which modifies vector habitats and expands the span of disease-carrying entities. Rubella diagnostic testing plays a crucial role in detecting and controlling rubella infections at an early stage, averting complications, primarily in expectant women, and supporting in controlling outbreaks to curb virus proliferation. For instance, as per the National Health Service, a government department based in the UK, in December 2023, the daily hospital admissions due to flu averaged 234, indicating a 53% enhancement from the preceding week, while hospital cases of norovirus swelled by 15% to a daily average of 406, displaying a 28% enhancement from the corresponding week the previous year. Thus, the escalating number of viral infection cases are steering the growth of the rubella diagnostic testing market.

How Is The Global Rubella Diagnostic Testing Market Broken Down By Segment?

The rubella diagnostic testingmarket covered in this report is segmented –

1) By Diagnostic Technique: Latex Agglutination; Liver Function Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (Ria); Fluorescent Immunoassay (FIA); Other Diagnostic Techniques

2) By Age Group: Neonates; Teenagers; Adults

3) By End User: Hospitals And Clinics; Cancer Diagnostic Centers; Ambulatory Surgical Centers; Other End Users

Subsegments:

1) By Latex Agglutination: Qualitative Latex Agglutination Tests; Quantitative Latex Agglutination Tests; Rapid Latex Agglutination Kits

2) By Liver Function Tests: Serum Bilirubin Tests; Alanine Aminotransferase (ALT) Tests; Aspartate Aminotransferase (AST) Tests; Alkaline Phosphatase (ALP) Tests; Other Liver Enzyme Tests

3) By Enzyme Immunoassay (EIA): Direct EIA; Indirect EIA; Sandwich EIA; Competitive EIA

4) By Radioimmunoassay (RIA): Standard RIA; Modified RIA; Single-Antibody RIA

5) By Fluorescent Immunoassay (FIA): Direct FIA; Indirect FIA; Sandwich FIA

6) Other Diagnostic Techniques: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAAT); Microplate-Based Assays; Western Blotting

Which Notable Trends Are Transforming The Rubella Diagnostic Testing Market Outlook?

Leading companies in the rubella diagnostic testing market are adopting strategies to create groundbreaking solutions, such as the rubella virus vaccine. This vaccine is designed to improve diagnosis precision and bolster preventative methods against rubella. The vaccine, offering immunity against rubella, is frequently dispensed as part of the MMR or MMRV combination vaccines to inhibit the disease and its related complications. For example, in March 2023, US-based pharmaceutical enterprise Merck & Co., Inc. gained FDA authorization for the intramuscular (IM) application of their M-M-R II vaccine, vital in offering protection from rubella, in addition to measles and mumps. This authorization permits healthcare practitioners to use the IM method to administer the rubella vaccine, aligning its administration with other standard pediatric vaccines. Immunization against rubella is fundamental in preventing outbreaks and safeguarding against the serious consequences the virus can precipitate, especially in pregnant women.

Who Are The Primary Market Leaders In The Rubella Diagnostic Testing Market?

Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/rubella-diagnostic-testing-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Rubella Diagnostic Testing Market?

North America was the largest region in the rubella diagnostic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=19177&type=smp

Browse Through More Reports Similar to the Global Rubella Diagnostic Testing Market 2025, By The Business Research Company

Bone And Mineral Diagnostic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model